A prominent cardiovascular health researcher at UK whose work is internationally recognized in the field of vascular biology, has been honored for her groundbreaking work by the American Heart Association.
With NIH support, Vince Venditto identified a cardiovascular biomarker that helps predicts risk of heart attack or stroke. He seeks to harness the immune system for treatment and prevention.
UK HealthCare’s Gill Heart & Vascular Institute Affiliate Network held their annual conference, bringing together a wide range of experts to learn and discuss the latest advancements and trends in cardiovascular medicine.
American Heart Association CEO, Nancy Brown, highlighted the historic collaboration between the AHA and UK during her featured presentation at the annual event.
The REBIRTH trial is hoping to provide the definitive answer as to whether bromocriptine has additional benefits to women in addition to standard medical therapy. UK is one of 50 centers across the country participating in REBIRTH.
The fellowship empowers undergraduates to become leaders for their respective communities by providing opportunities to develop knowledge and skills through research within UK’s Research Priority Areas.
